Forty years of neurotransmitters: A personal account

Archives of General Psychiatry

Volumn 59, Issue 11, 2002, Pages 983-994

  Snyder, Solomon H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; BENZATROPINE MESILATE; BIPERIDEN; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CODEINE; DEXTROMETHORPHAN; DOPAMINE; ENKEPHALIN; HALOPERIDOL; LEVODOPA; METHYLXANTHINE; NALOXONE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; NORADRENALIN; OLANZAPINE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; PHENOTHIAZINE DERIVATIVE; PSYCHOTROPIC AGENT; RESERPINE; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL; UNINDEXED DRUG;

AGRANULOCYTOSIS; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DYSURIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPOTENSION; NAUSEA; NEUROTRANSMISSION; NEUROTRANSMITTER UPTAKE; NONHUMAN; PAIN; PARKINSON DISEASE; PSYCHOPHARMACOLOGY; REVIEW; SEDATION; SIDE EFFECT; VISUAL IMPAIRMENT; XEROSTOMIA;

ANIMALS; BRAIN; BRAIN CHEMISTRY; HISTORY, 20TH CENTURY; HUMANS; NEUROTRANSMITTER AGENTS; PSYCHIATRY; PSYCHOTROPIC DRUGS;

EID: 0036841941     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.11.983     Document Type: Review

References (99)

1. Axelrod J. Noradrenaline: Fate and control of its biosynthesis. Science. 1971;173:598-606.
2. Glowinski J, Axelrod J. Effects of drugs on the disposition of H3-norepinephrine in the rat brain. Pharmacol Rev. 1966;18:775-785.
3. Iversen LL. The Uptake and Storage of Noradenaline in Sympathetic Nerves. Cambridge, England: Cambridge University Press; 1967.
4. Snyder SH, Green AI, Hendley ED. Kinetics of H3-norepinephrine accumulation into slices from different regions of rat brain. J Pharm Exp Ther. 1968;164:90-102.
5. Shaskan EG, Snyder SH. Kinetics ofserotonin uptake into slices from different regions of rat brain. J Pharm Exp Ther. 1970;175:404-418.
6. Coyle JT, Snyder SH. Catecholamine uptake by synaptosomes in homogenates of rat brain: Stereospecificity in different areas. J Pharm Exp Ther. 1969;170:221-231.
7. Coyle JT, Snyder SH. Antiparkinsonian drugs: Inhibition of dopamine uptake in the corpus striaturn as a possible mechanism of action. Science. 1969;166:899-901.
8. Curtis DR, Duggan AW, Felix O, Johnston GAR. GABA, bicuculline and central inhibition. Nature. 1970;226:1222-1224
9. Watkins JC. L-glutamate as a central neurotransmitter: Looking back. Biochem Soc Trans. 2000;28:297-310.
10. Werman R, Davidoff RA, Aprison MH. Inhibiting actions of glycine on spinal neurons in the cat. J Neurophysiol. 1968;31:81-95.
11. Curtis DR, Johston GAR. Strychnine, glycine and vertebrate postsynaptic inhibition. Nature. 1970;225:1258-1259.
12. Logan WJ, Snyder SH. Unique high affinity uptake systems for glycine, glutamic and aspartic acids in central nervous tissue of the rat. Nature. 1971;234:297-299.
13. Bennett JP, Logan WJ, Snyder SH. Amino acid neurotransmitter candidates: Sodium-dependent high-affinity uptake by unique synaptosomal fractions. Science. 1972;178:997-999.
14. Mulder AH, Snyder SH. Potassium-induced release of amino acids from cerebral cortex and spinal cord slices of the rat. Brain Res. 1974;76:297-308.
15. Changeaux JP. The cholinergic receptor protein from fish electric organ. In: Iversen LL, Iversen SD, Snyder SH, eds. Handbook of Psychopharmacology. Vol 6. New York, NY: Plenum Press; 1975:235-301.
16. Dole VP. Biochemistry of addiction. Ann Rev Biochem. 1970;39:821-840.
17. Goldstein A, Lowrey LI, Pal BK. Stereospecific and nonspecific interaction of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A. 1971;68:1742-1747.
18. Loh HH, Cho TM, Wu YC, Way EL. Stereospecific binding of narcotics to brain cerebrosides. Life Sci. 1974;14:2231-2245.
19. Pert C, Snyder SH. Opiate receptor: Demonstration in nervous tissue. Science. 1973;179:1011-1014.
20. Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol Toxicol. 1973;32:317-320.
21. 3H) etorphine to rat brain homogenate. Proc Natl Acad Sci U S A. 1973;70:1947-1949.
22. Kuhar MJ, Pert CB, Snyder SH. Regional distribution of opiate receptor binding in monkey and human brain. Nature 1973;245:447-450.
23. Pert CB, Kuhar MJ, Snyder SH. Opiate receptor: Autoradiographic localization in rat brain. Proc Natl Acad Sci U S A. 1976;73:3729-3733.
24. Pert CB, Pasternak GW, Snyder SH. Opiate agonists and antagonists discriminated by receptor binding in brain. Science. 1973;182:1359-1361.
25. Pasternak GW, Goodman R, Snyder SH. An endogenous morphine-like factor in mammalian brain. Life Sci. 1975;16:1765-1769.
26. Snyder SH. Opiate receptor in normal and drug altered brain function. Nature 1975;257:185-189.
27. Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res. 1975;88:295-308.
28. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975;258:577-580.
29. Simantov R, Snyder SH. Morphine-like peptides in mammalian brain: Isolation, structure, elucidation, and interactions with the opiate receptor. Proc Natl Acad Sci U S A. 1976;73:2515-2519.
30. Simantov R, Kuhar MJ, Uhl GR, Snyder SH. Opioid peptide enkephalin: Immunohistochemical mapping in rat central nervous system. Proc Natl Acad Sci U SA. 1977;74:2167-2171.
31. Neale JH, Baker JL, Uhl GR, Snyder SH. Enkephalin containing neurons visualized in spinal cord cell cultures. Science. 1978;201:467-469.
32. Jessell TM, Iversen LL. Opiate analgesics inhibit substance P release from the rat trigeminal nucleus. Nature. 1977;268:549-551.
33. Yamamura H.I., Snyder SH. Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci U S A. 1974;71:1725-1729.
34. Young AB, Snyder SH. Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci U S A. 1973;70:2832-2836.
35. Banerjee SP, Snyder SH, Cuatrecasas P, Greene LA. Binding of nerve growth factor receptor in sympathetic ganglia. Proc Natl Acad Sci U S A. 1973;70:2519-2523.
36. Zukin SR, Young AB, Snyder SH. Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci U S A. 1974;71:4802-4807.
37. Bennett JP Jr, Snyder SH. Stereospecific binding of d-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors. Brain Res. 1975;94:523-544.
38. Murphy KM, Snyder SH. Calcium antagonist receptor binding sites laveled with 3H-nitrendipine. Eur J Pharmacol. 1982;77:201-202.
39. Creese I, Burt DR, Snyder SH. Dopamine receptor binding, differentiation of agonist and antagonist states with 3H dopamine are 3H haloperidol. Life Sci. 1975;17:993-1002.
40. Greenberg DA, U'Prichard DC, Snyder SH. Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist states. Life Sci. 1976;19:69-76.
41. Bennett JP, Snyder SH. Angiotensin II binding to mammalian brain membranes. J Biol Chem. 1976;23:7423-7430.
42. Uhl GR, Bennett JP, Snyder SH. Neurotensin, a central nervous system peptide: Apparent receptor binding in brain membranes. Brain Res. 1977;130:299-313.
43. 3H] mepyramine. Proc Natl Acad Sci U S A. 1978;75:6290-6294.
44. Innis RB, Manning DC, Stewart JM, Snyder SH. 3H-bradykinin receptor binding in mammalian tissue membranes. Proc Natl Acad Sci U S A. 1981; 78:2630-2634
45. Innis RB, Snyder SH. Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci U S A. 1980;77:6917-6921.
46. Bruns RF, Daly JW, Snyder SH. Adenosine receptors in brain membranes: Binding of N6-cyclohexyl [3H] adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci U S A. 1980;77:5547-5551.
47. Seeman P, Chau-Wong M, Tedesco I, Wong K. Brain receptors for antipsychotic drugs and dopamine: Direct binding assays. Proc Natl Acad Sci U S A. 1975;72:4376-4380.
48. Kehabian JW, Petzold GL, Greengard P. Dopamine sensitive adenylate cyclase in caudate nucleus of rat brain and its similarity to the "dopamine receptor." Proc Natl Acad Sci U S A. 1972;69:2145-2149.
49. Carlsson A, Lindquist M. Effect of chlorpromazine or haloperidol on the formation of 3-methoxytyramine and normetanephrire in mouse brain. Acta Pharmacol. 1963;20:140-144.
50. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976;192:481-483.
51. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 1976;261:717-719.
52. Bennett JP Jr, Snyder SH. Serotonin and lysergic acid diethylamide binding in rat brain membranes: Relationship to postsynaptic serotonin receptors. Mol Pharmacol 1976;12:373-389.
53. Creese I, Snyder SH. 3H-spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 1978;49:201-202.
54. Peroutka SJ, Lebovitz RM, Snyder SH. Two distinct central serotonin receptors with different physiological functions. Science. 1981;212:827-829.
55. Peroutka SJ, Snyder SH. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic and histamine receptors to clinical potency. Am J Psychiatry. 1980;137:1518-1522.
56. Snyder SH, Greenberg D, Yamamura HI. Antischizophrenic drugs and brain cholinergic receptors. Arch Gen Psych. 1974;31:58-61.
57. Miller RJ, Hiley CR. Anti-muscarinic properties of neuroleptics and drug-induced parkinsonian. Nature. 1974;248:596-597.
58. U'Prichard DC, Snyder SH. Binding of 3H-catecholamines to α-noradrenergic receptor sites in calf brain. J Biol Chem. 1977;252:6450-6463.
59. Peroutka SJ, Greenberg DA, U'Prichard DC, Snyder SH. Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: Implications for a two-site model of alpha receptor function. Mol Pharmacol. 1978;14:403-412.
60. U'Prichard DC, Snyder SH. Distinct α-noradrenergic receptors differentiated by binding and physiological relationships. Life Sci. 1979;24:79-88.
61. Peroutka SJ, U'Prichard DA, Greenberg DA, Snyder SH. Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacol. 1977;16:549-556.
62. U'Prichard DC, Greenberg DA, Sheehan PP, Snyder SH. Tricyclic antidepressants: Therapeutic properties and affinity for α-noradrenergic receptor binding sites in the brain. Science. 1978;199:197-198.
63. Sutherland EW. Studies on the mechanism of hormone action. Science. 1972;177:401-408.
64. Streb H, Irvine RF, Berridge MJ, Schulz I. Release of Ca2+ from non-mitochondrial intracellular stores in pancreatic cancer cells by inositol 1,4,5-trisphosphate. Nature. 1983;306:67-69.
65. Worley PF, Baraban JM, Colvin JS, Snyder SH. Inositol trisphosphate receptor localization in brain: Variable stoichiometry with protein kinase C. Nature. 1987;325:159-161.
66. Supattapone S, Worley PF, Baraban JM, Snyder SH. Solubilization, purification and characterization of an inositol trisphosphate receptor. J Biol Chem. 1988;263:1530-1534.
67. Ferris CD, Huganir RL, Supattapone S, Snyder SH. Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles. Nature. 1989;342:87-89.
68. Voglmaier SM, Bembenek ME, Kaplin AI, Dorman G, Olszewski JD, Prestwich GD, Snyder SH. Purified inositol hexakisphosphate as a high energy phosphate donor. Proc Natl Acad Sci U S A. 1996;93:4305-4310.
69. Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH. Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polykisphosphate kinases. Curr Biol. 1999;9:1323-1326.
70. Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, Snyder SH. High brain densities of the immunophilin FKBP are colocalized with calcineurin. Nature. 1992;358:584-587.
71. Lyons EW, George EB, Dawson TM, Steiner JP, Snyder SH. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci U S A. 1994;91:3191-3195.
72. Steiner JP, Connolly Maureen A, Valentine HL, Hamilton GS, Dawson TM, Hester L, Snyder SH. Neurotrophic actions of nonimmunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med. 1997;3:421-428.
73. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, Liang S, Ramsey C, Li JH, Huang W, Howorth P, Seri R, Fuller M, Sauer H, Nowotnik AC, Suzdak PD. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci U S A. 1997;94:2019-2024.
74. Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med. 2001;7:1073-1074.
75. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med. 1993;329:2002-2012.
76. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A. 1989;86:9030-9033.
77. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682-685.
78. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714-718.
79. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A. 1991;88:6368-6371.
80. Nowicki JP, Duval D, Poignet H, Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol. 1991; 204:339-340.
81. Huang Z, Huang DL, Panachian N, Duikara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883-1885.
82. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 1995;378:383-386.
83. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: A physiological mediator of penile erection. Science. 1992;257:401-403.
84. Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarty JL, Snyder SH, Burnett AL. Akt-dependent phosphorylation of endothelial nitricoxide synthase mediates penile erection. Proc Nat Acad Sci U S A. In press.
85. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A. 1992;89:7674-7677.
86. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH. Protein S-nitrosylation: A physiological signal for neuronal nitric oxide. Nat Cell Biol. 2001;3:193-197.
87. Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, Snyder SH. Capon: A protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron. 1998;20:115- 124.
88. Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH. Dexras 1: A G protein specifically coupled to neuronal nitric oxide synthase via capon. Neuron. 2000;28:183-193.
89. Maines MD, Prakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase: Only one molecular species of the enzyme is inducible. J Biol Chem. 1986;261:411-419.
90. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: A putative neural messenger. Science. 1993;259:381-384.
91. Zakhary R, Poss KD, Jaffrey SR, Ferris CD, Tonegawa S, Snyder SH. Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proc Natl Acad Sci U S A. 1997;94: 14848-14853.
92. Xue L, Farrugia G, Miller SM, Ferris CD, Snyder SH, Szurszewski JH. Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes. Proc Natl Acad Sci U S A. Vol. 2000;97:1851-1855.
93. Dore S, Takahashi M, Ferris CD, Hester LD, Guastella D, Snyder SH. Bilirubin formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A. 1999;96:2445-2450.
94. Baranano D, Snyder SH. Neural roles for heme oxygenase: Contrasts to nitric oxide synthase. Proc Natl Acad Sci U S A. 2001;98:10996-11002.
95. Hashimoto A, Nishikowa T, Oka T, Takahashi K. Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging J Neurochem. 1993;60:783-786.
96. Schell MJ, Molliver ME, Snyder SH. D-serine, an endogenous synaptic modulator: Localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci U S A. 1995;92: 3948-3952.
97. Mothet JP, Parent AT, Wolosker H, Brady Jr R, Linden DJ, Ferris CD, Rogawski MA, Snyder SH. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 2000;97:4926-4931.
98. Wolosker H, Blackshaw S, Snyder SH. Serine racemase: A glial enzyme synthesizing D-serine to regulate glutamate N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci U S A. 1999;96:13409-13414.
99. Snyder SH, Karims JJ, Annau Z, Bruns RF, Daly JW. Adenosine receptors and behavioural actions of methylxanthines. Proc Natl Acad Sci USA. 1981;78:3260-3264.